CONSORT: Screening, Randomization, Baseline Imaging and Follow-up.

<p>CONSORT: Screening, Randomization, Baseline Imaging and Follow-up.</p

Subject Characteristics at Baseline and 3 Years after the Target Quit Date^*.

*<p>all values are means (standard deviation); ANOVA  =  analysis of variance, CIMT  =  carotid intima-media thickness</p>a<p> =  significantly different from intermittent smokers (p<0.05), based on a post-hoc Tukey test</p>b<p> =  significantly different from continuous smokers (p<0.05), based on a post-hoc Tukey test</p>c<p> =  significantly different from continuously abstinent (p<0.05), based on a post-hoc Tukey test</p

Smoking Cessation and the Risk of Diabetes Mellitus and Impaired Fasting Glucose: Three-Year Outcomes after a Quit Attempt

<div><p></p><p>Weight gain after smoking cessation may increase diabetes mellitus and impaired fasting glucose (IFG) risk. This study evaluated associations between smoking cessation and continued smoking with incident diabetes and IFG three years after a quit attempt. The 1504 smokers (58% female) were mean (standard deviation) 44.7 (11.1) years old and smoked 21.4 (8.9) cigarettes/day. Of 914 participants with year 3 data, the 238 abstainers had greater weight gain, increase in waist circumference, and increase in fasting glucose levels than the 676 continuing smokers (p≤0.008). In univariate analyses, Year 3 abstinence was associated with incident diabetes (OR = 2.60, 95% CI 1.44–4.67, p = .002; 4.3% absolute excess) and IFG (OR = 2.43, 95% CI 1.74–3.41, p<0.0001; 15.6% absolute excess). In multivariate analyses, incident diabetes was associated independently with older age (p = 0.0002), higher baseline body weight (p = 0.021), weight gain (p = 0.023), baseline smoking rate (p = 0.008), baseline IFG (p<0.0001), and baseline hemoglobin A1C (all p<0.0001). Smoking more at baseline predicted incident diabetes among eventual abstainers (p<0.0001); weighing more at baseline predicted incident diabetes among continuing smokers (p = 0.0004). Quitting smoking is associated with increased diabetes and IFG risk. Independent risk factors include older age, baseline body weight, baseline glycemic status, and heavier pre-quit smoking. These findings may help target smokers for interventions to prevent dysglycemia.</p><p>Trial Registration</p><p>Clinicaltrials.gov <a href="http://www.clinicaltrials.gov/ct2/show/NCT00332644." target="_blank">NCT00332644</a></p></div

Subject Characteristics at Baseline and Year 3.

<p>ECG = electrocardiogram cpd = cigarettes per day.</p>*<p>Carbon monoxide levels for the current smokers at year 3 was 19.1(11.0) ppm.</p>**<p>Cigarettes per day for the current smokers at year 3 was 13.5 (8.2) cpd.</p

Prevalence of Major and Minor ECG Abnormalities.

<p>The percentage of subjects with major and minor ECG abnormalities at baseline (blue) and at year 3 (red). Year 3 percentages include both continued smokers and those who abstained. All p-values for comparisons between baseline and year 3 ECG abnormalities were non-significant (<0.05). <i>ECG = electrocardiogram. *Subjects may have had more than one major and/or minor ECG abnormalities. Each abnormality was tallied separately.</i></p

Univariate Predictors of Year 3 Glycemic Group Status.

<p><i>IFG  =  impaired fasting glucose; DM  =  diabetes mellitus.</i></p><p><i>Asterisks indicate significance levels for the variables in the prediction of either Year 3 IFG or diabetes mellitus by univariate multinomial logistic regressions; the group consisting of participants with normal glycemic status was the reference condition for the IFG and DM groups:</i><b>*  = p<0.05; **  = p<0.01; ***  = p<0.0001.</b></p

Mixed-Effects Models Testing Selected Repeated Measures as a Function of Time and Year 3 Smoking Status.

<p><i>All values are mean (standard deviation); note: 89 participants with diabetes mellitus at baseline are omitted from these analyses.</i></p

Best-Fitting Multivariate Multinomial Logistic Regression Model Predicting Year 3 Glucose Group (Normal, Impaired Fasting Glucose, Diabetes Mellitus).

<p><i>Reference group  =  normal Year 3 glycemic status.</i></p><p><i>IFG  =  impaired fasting glucose.</i></p

Baseline Participant Characteristics by Year 3 Smoking and Missingness Status.

<p><i>All values are mean (standard deviation); *with post-hoc tests of significant group differences.</i></p

(A). Prevalence of Specific Major ECG Abnormalities. (B). Prevalence of Specific Minor ECG Abnormalities.

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0062311#pone-0062311-g002" target="_blank">Figure 2A</a> shows percentages of the specific major ECG abnormalities and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0062311#pone-0062311-g002" target="_blank">figure 2B</a> shows percentages of the specific minor ECG abnormalities at baseline (blue) and at year 3 (red). Year 3 percentages include both continued smokers and those who abstained. All p-values for comparisons between baseline and year 3 ECG abnormalities were non-significant (<0.05). BBB = Bundle Branch Block; AV = Atrioventricular.</p